Option chain shows key data for 180 Life Sciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for 180 Life Sciences.

180 Life Sciences (NASDAQ:ATNF) Stock, Option Chain

180 Life Sciences

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.

Wall-Street-dall

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ATNF

BREA

NIXX

STAF

STEC

Dow Jumps Over 100 Points; Alcoa Profit Beats Estimates

movers image

Pre-Market Outlook

Movers

CLMT

CTCX

EFSH

GEVO

GRTS

KLTO

LCID

MTEM

PRQR

QNRX

SAIH

VINE

VSME

Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Crollo del Nasdaq: gli insider si sbarazzano di questi titoli

AMPS

NVAX

SVCO

Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates

180 Life Sciences Corp

Management

Press Releases

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer

180 Life Sciences Corp. - Corporate Updates

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector

180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform

Elray Resources Announces Strategic Sale of Crypto iGaming Technology

180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

Offerings

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

ELRA

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Aptevo Therapeutics

Azitra

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Capstone Holding

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Ensysce Biosciences

Entero Therapeutics

Genprex

GRI Bio

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Organovo Holdings

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Polyrizon

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Tharimmune

Theriva Biologics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Comments

180 Life Sciences

180 Life Sciences (ATNF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga